Synergistic Effect between the APOE ε4 Allele with Genetic Variants of GSK3B and MAPT : Differential Profile between Refractory Epilepsy and Alzheimer Disease
Temporal Lobe Epilepsy (TLE) is a chronic neurological disorder characterized by recurrent focal seizures originating in the temporal lobe. Despite the variety of antiseizure drugs currently available to treat TLE, about 30% of cases continue to have seizures. The etiology of TLE is complex and mult...
Gespeichert in:
Veröffentlicht in: | International journal of molecular sciences 2024-09, Vol.25 (18), p.10228 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Temporal Lobe Epilepsy (TLE) is a chronic neurological disorder characterized by recurrent focal seizures originating in the temporal lobe. Despite the variety of antiseizure drugs currently available to treat TLE, about 30% of cases continue to have seizures. The etiology of TLE is complex and multifactorial. Increasing evidence indicates that Alzheimer's disease (AD) and drug-resistant TLE present common pathological features that may induce hyperexcitability, especially aberrant hyperphosphorylation of tau protein. Genetic polymorphic variants located in genes of the microtubule-associated protein tau (
) and glycogen synthase kinase-3β (
) have been associated with the risk of developing AD. The
allele is a major genetic risk factor for AD. Likewise, a gene-dose-dependent effect of
seems to influence TLE. The present study aimed to investigate whether the
allele and genetic variants located in the
and
genes are associated with the risk of developing AD and drug-resistant TLE in a cohort of the Mexican population. A significant association with the
allele was observed in patients with AD and TLE. Additional genetic interactions were identified between this allele and variants of the
and
genes. |
---|---|
ISSN: | 1422-0067 1661-6596 1422-0067 |
DOI: | 10.3390/ijms251810228 |